???global.info.a_carregar???
Concluiu o Doutoramento em Ciências Farmacêuticas, na especialidade de Farmácia Clínica, em 2017, pela Universidade de Coimbra, o Mestrado em Biotecnologia Farmacêutica, em 2012, pela Universidade de Coimbra, e o Mestrado Integrado em Ciências Farmacêuticas, em 2009, pela Universidade de Coimbra.
Identification

Personal identification

Full name
Diogo Manuel de Jesus Mendes

Citation names

  • Mendes, Diogo

Author identifiers

Ciência ID
AA18-214C-5D5A
ORCID iD
0000-0003-4923-8717

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Spanish; Castilian Beginner (A1) Intermediate (B1) Beginner (A1) Intermediate (B1) Elementary (A2)
Education
Degree Classification
2013 - 2017
Concluded
 Ciências Farmacêuticas, especialidade de Farmácia Clínica (Doutoramento)
Universidade de Coimbra, Portugal
"Benefit-risk assessment of medicines: a contribution for evidence-based decisions using the number needed to treat to benefit or to harm" (THESIS/DISSERTATION)
 Aprovado c/ distinção e louvor
2010 - 2012
Concluded
 Mestrado em Biotecnologia Farmacêutica (Mestrado)
Universidade de Coimbra, Portugal
"Iatrogenia de medicamentos biológicos indicados no tratamento da artrite reumatóide : análise de notificações espontâneas de suspeitas de reações adversas em Portugal" (THESIS/DISSERTATION)
 17
2004 - 2009
Concluded
 Mestrado Integrado em Ciências Farmacêuticas (Licenciatura)
Universidade de Coimbra, Portugal
 14
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2021/09 - Current Invited Assistant Professor (University Teacher) Universidade de Coimbra Faculdade de Farmácia, Portugal

Others

Category
Host institution 		Employer
2022/01 - Current CEO Clevidence, Portugal
2020/11 - 2022/01 Diretor do Centro de Avaliação de Tecnologias de Saúde e Investigação do Medicamento Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2018/01 - 2022/01 Investigador Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2011/04 - 2022/01 Assistente de Investigação Unidade de Farmacovigilância do Centro, Portugal
2011/04 - 2018/04 Farmacêutico Farmácia Nuno Álvares, Portugal
2011/04 - 2017/12 Assistente de Investigação Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2010/01 - 2011/06 Farmacêutico Farmácia Machado, Portugal
2009/09 - 2009/11 Farmacêutico Farmácia Torres e Correia, Portugal
Outputs

Publications

Conference poster
  1. Ribeiro, Catarina; Penedones, Ana; Mendes, Diogo; Alves, Carlos. "HTA338 Characterization of the Evidence Supporting the Relative Effectiveness Evaluations in Health Technologies Assessment: A Review". Paper presented in ISPOR Europe 2023, 2023.
    10.1016/j.jval.2023.09.2021
  2. Ribeiro, C.; Penedones, Ana; Mendes, Diogo; Alves, Carlos. "HTA46 Relationship Between the Directness of the Evidence and Identification of Added Therapeutic Value: An Analysis of HTA Procedures". Paper presented in ISPOR Europe 2023, 2023.
    10.1016/j.jval.2023.09.1731
  3. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Numbers needed to treat to benefit (NNTB) and to harm (NNTH) for COVID-19 medicines". Paper presented in 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 2022.
  4. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "JAK inhibitors for atopic dermatitis: A network meta-analysis of adverse events". Paper presented in 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 2022.
  5. Abrantes, Joana; Tavares, Inês; Penedones, Ana; Figueiredo, Daniel; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal". Paper presented in 21st International Society of Pharmacovigilance Annual Meeting, 2022.
  6. Tavares, Inês; Penedones, Ana; Abrantes, Joana; Mendes, Diogo; Codeco, C; Rigueiro, Graça; Alves, Carlos; Batel-Marques, Francisco. "Adverse Reactions Associated with Comirnaty® Among Healthcare Professionals: A Cohort Event Monitoring Study in a Portuguese Hospital". Paper presented in 21st International Society of Pharmacovigilance Annual Meeting, 2022.
  7. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "JAK inhibitors and the risk of cardiovascular and venous thromboembolism events among patients with rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 37th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2021.
  8. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "Risk of cardiovascular and venous thromboembolism events among JAK inhibitors used in rheumatoid arthritis: a network meta-analysis of clinical trials". Paper presented in EACPT Virtual Meeting - Focus on Progress in Clinical Pharmacology, 2021.
  9. Penedones, Ana; Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "Risk of infections among JAK inhibitors used in rheumatoid arthritis: a network meta-analysis of clinical trials". Paper presented in EACPT Virtual Meeting - Focus on Progress in Clinical Pharmacology, 2021.
  10. Abrantes, Joana; Mendes, Diogo; Batel-Marques, Francisco. "The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register): Preliminary Results". Paper presented in 20th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2021.
  11. Abrantes, Joana; Tavares, Inês; Mendes, Diogo; Penedones, Ana; Alves, Carlos; Batel-Marques, Francisco. "Unexpected Adverse Reactions Reported for COVID-19 Vaccines: A Descriptive Analysis of Spontaneous Reports Received by a Portuguese Regional Pharmacovigilance Unit". Paper presented in 20th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2021.
  12. Batel-Marques, Francisco; Pereira, Diogo; Mendes, Diogo; Alves, Carlos; Penedones, Ana. "Real-world outcomes versus clinical trials results with dipeptidyl peptidase-4 inhibitors: a systematic review protocol". Paper presented in 13th International Conference on Advanced Technologies & Treatments for Diabetes, 2020.
  13. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Marques, Francisco Batel. "Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 36th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2020.
  14. Gomes, Rita; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Polypharmacy as an independent risk factor for serious adverse drug reactions: A systematic review". Paper presented in 36th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2020.
  15. Alves, Carlos; Mendes, Diogo; Penedones, Ana; Marques, Francisco Batel. "Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials". Paper presented in 36th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2020.
  16. Mendes, Diogo; Rigueiro, Graça; Silva, Rui Sousa; Penedones, Ana; Alves, Carlos; Sousa, Gabriela; Batel-Marques, Francisco. "A pilot intensive safety surveillance scheme for medicines under additional monitoring used in the treatment of cancer". Paper presented in 19th ISOP Annual Meeting, 2019.
  17. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "A comparison of the safety of apixaban, rivaroxaban and dabigatran: an indirect treatment comparison using real-world studies.". Paper presented in 19th International Society of Pharmacovigilance Annual Meeting, 2019.
  18. Mendes, Diogo; Rigueiro, Graca; Silva, Rui Sousa; Penedones, Ana; Alves, Carlos; Sousa, Gabriela; Marques, Francisco Batel. "Intensive safety surveillance of anticancer medicines subject to additional monitoring: A pilot study". Paper presented in 35th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2019.
  19. Alves, Carlos; Mendes, Diogo; Batel Marques, Francisco. "Risk of tendinopahty associated with fluoroquinolones: A systematic review and meta-analysis". Paper presented in 35th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2019.
  20. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "Comparing the Safety of Apixaban, Rivaroxaban and Dabigatran: Indirect Treatments Comparisons Using Real-World Studies". Paper presented in 35th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2019.
  21. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "Fluoroquinolones and risk of tendinopahty: a systematic review and meta-analysis of observational studies". Paper presented in 19th ISOP Annual Meeting, 2019.
  22. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Systematic reviews assessing drug's safety in Ophthalmology". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, 2017.
  23. Alves, Carlos; Mendes, Diogo; Batel Marques, Francisco. "Risk of cataracts associated with statins: a cumulative meta-analysis". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2017.
  24. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Systematic Reviews in Ophthalmology: Methodological Considerations". Paper presented in 33th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2017.
  25. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "Mortality and Cardiovascular Events Associated with DDP-4 Inhibitors: A Meta-Analysis of Observational Studies". Paper presented in 33th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2017.
  26. Mendes, Diogo; Alves, Carlos; Marques, Francisco Batel. "Application of the Number Needed to Treat (NNT) in Medical Literature: A Methodological Assessment". Paper presented in 33th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2017.
  27. Alves, Carlos; Mendes, Diogo; Marques, Francisco Batel. "A Cumulative Meta-Analysis Evaluating the Risk of Cataracts Associated with Statins". Paper presented in 33th International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2017.
  28. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "The use of the number needed to treat (NNT) to asses the effects of medicinal interventions: a quality assessment". Paper presented in 13th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2017.
  29. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Treatment with MEK inhibitors and risk of ocular toxicity: a systematic review and meta-analysis". Paper presented in IV Reunião Científica Anual - Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia, 2016.
  30. Batel Marques, Francisco; Penedones, Ana; Alves, Carlos; Mendes, Diogo. "Costs associated with adverse drug events: a systematic review". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  31. Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Multiple drug exposure as risk factor for serious adverse drug reactions". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  32. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Is the number needed to harm a useful metric for the assessment of benefit-risk ratios of drugs? A case study with drugs withdrawn from the EU market due to safety reasons". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  33. Penedones, Ana; Ribeiro, Inês; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "The contribution of community pharmacies to Central Portugal Regional Pharmacovigilance Unit activity". Paper presented in IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), 2016.
  34. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Applying the number needed to harm (NNH) to benefit-risk (BR) assessments of drugs withdrawn from the market due to safety reasons". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  35. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "Ophthalmic adverse effects in cancer patients treated with MEK inhibitors: a meta-analysis". Paper presented in 32nd International Conference on Pharmacoepidemiology (ICPE) and Therapeutic Risk Management, 2016.
  36. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco; Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "A Meta-analysis evaluating the risk of ophthalmic adverse events associated with MEK inhibitors". Paper presented in 16th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2016.
  37. Alves, Carlos; Ribeiro, Inês; Mendes, Diogo; Penedones, Ana; Batel Marques, Francisco. "Ophthalmic adverse effects in cancer patients treated with MEK inhibitors: a systematic review and meta-analysis". Paper presented in 13th International Symposium on Ocular Pharmacology and Therapeutics (ISOPT) Clinical, 2016.
  38. Batel Marques, Francisco; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Dias, Patricia; Martins, Angelina; Santiago, Luiz Miguel; et al. "Pharmacovigilance in Portugal: Activity of the Central Pharmacovigilance Unit". Paper presented in 2015 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium, 2015.
  39. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "A Systematic Review and Meta-Analysis Evaluating the Association between Fluoroquinolones use and Development of Retinal Detachment". Paper presented in 2015 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium, 2015.
  40. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Application of quantitative methodologies for benefit-risk assessment: case study with rosiglitazone and pioglitazone". Paper presented in 31st International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2015.
  41. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Ocular adverse drug events: analysis of spontaneous reports from a Portuguese regional pharmacovigilance database". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  42. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Number needed to harm as a tool for post-marketing drug safety evaluation: a pilot study with thiazolidinediones". Paper presented in 15th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2015.
  43. F Batel-Marques; A Penedones; C Alves; D Mendes. "Costs of Adverse Drug Events: Systematic Review". Paper presented in International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual European Congress, 2015.
    10.1016/j.jval.2015.09.1571
  44. A. Penedones; D. Mendes; C. Alves; F. Batel Marques. "Ocular adverse events induced by Drugs: a review of the safety alerts issued by Health Regulatory Authorities". Paper presented in 12th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2015.
    10.1016/j.clinthera.2015.05.350
  45. Mendes, Diogo; Dias, Patricia; Alves, Carlos; Batel Marques, Francisco. "Antibiotics-induced liver injury: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events". 2015.
  46. C. Alves; A. Penedones; D. Mendes; F. Batel Marques. "The efficacy and safety of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: a systematic review and meta-analysis". Paper presented in 12th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), 2015.
    10.1016/j.clinthera.2015.05.352
  47. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "Fluoroquinolones use and Development of Retinal Detachment: a Systematic Review and Meta-analysis". Paper presented in 31st International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2015.
  48. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel-Marques, Francisco. "Adverse events associated with canagliflozin mechanism of action: a meta-analysis of randomized clinical trials". Paper presented in 14th ISOP Annual Meeting, 2014.
  49. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety profile of adalimumab, etanercept and infliximab: analysis of disproportionalities in a Pharmacovigilance database". Paper presented in 2014 American College of Clinical Pharmacy (ACCP) Virtual Poster Symposium, 2014.
  50. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Cases of anaphylaxis associated with the use of drugs: analysis of a Pharmacovigilance database". Paper presented in 30th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2014.
  51. Alves, Carlos; Macedo, Ana Filipa; Mendes, Diogo; Batel Marques, Francisco. "Drug-safety alerts issued by regulatory authorities: usefulness of meta-analysis in predicting earlier risks". Paper presented in 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  52. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety monitoring of ophthalmic biologics: a systematic review of pre and post-marketing safety data". Paper presented in 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  53. Alves, Carlos; Mendes, Diogo; Andrade, Sofia; Batel-Marques, Francisco. "The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer – A Systematic Review". Paper presented in International Society For Pharmacoeconomics and Outcomes Research (ISPOR) 17th Annual European Congress, 2014.
    10.1016/j.jval.2014.08.2197
  54. Dias, Patrícia; Penedones, Ana; Mendes, Diogo; Fontes Ribeiro CA; Batel-Marques, Francisco. "Drug Safety Signals Generation Using Disproportionality Analysis of Spontaneous Reporting Databases - A Systematic Review". Paper presented in 13th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  55. Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Quantitative Benefit-Risk Assessment of Rosiglitazone: Number Needed to Treat, Number Needed to Harm and Likelihood to be Helped or Harmed". Paper presented in 14th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2014.
  56. Alves, Carlos; Macedo, Ana Filipa; Mendes, Diogo; Fontes Ribeiro, Carlos; Batel Marques, Francisco. "Statin therapy and incidence of cataracts: a meta-analysis". Paper presented in 13th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2013.
  57. Barata, Inês; Alves, Carlos; Mendes, Diogo; Fontes Ribeiro, Carlos; Batel Marques, Francisco. "The preventability of adverse drug reactions occurring with antineoplastic drugs – an evaluation of spontaneously reported cases". Paper presented in 13th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2013.
  58. Alves, Carlos; Macedo, Ana F.; Mendes, Diogo; Marques, Francisco Batel. "Statin Therapy and Incident Cataract: A Meta-Analysis". Paper presented in 13th International Society of Pharmacovigilance (ISoP) Annual Meeting, 2013.
  59. Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel Marques, Francisco. "Spontaneous reporting of adverse drug reactions: a ten years' contribution of the activity of the Regional Pharmacovigilance Unit of Central Portugal for drug safety knowledge". Paper presented in 6th European Congress of Pharmacology, 2012.
  60. Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel Marques, Francisco. "Ten Years of Activity of the Regional Pharmacovigilance Unit of Central Portugal and Its Contribution for Drug Safety Knowledge". Paper presented in 28th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2012.
  61. Batel Marques, Francisco; Alves, Carlos; Mendes, Diogo; Fontes Ribeiro, Carlos. "Severity of Adverse Drug Reactions Reported from Hospitals and Ambulatory Care Settings in Central Portugal: An Update". Paper presented in 28th International Conference on Pharmacoepidemiology (ICPE) & Therapeutic Risk Management, 2012.
  62. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Unidade de Farmacovigilância do Centro: estudo da casuística". Paper presented in Conferência do Centro de Estudos Farmacêuticos (CEF), 2011.
Journal article
  1. Carlos Alves; Diogo Mendes; Ana Penedones; Tânia Oliveira; António Donato; Francisco Batel-Marques. "The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies". International Journal of Clinical Pharmacy (2024): https://doi.org/10.1007/s11096-023-01666-x.
    10.1007/s11096-023-01666-x
  2. Diogo Mendes; Daniel Figueiredo; Carlos Alves; Ana Penedones; Beatriz Costa; Francisco Batel-Marques. "Impact of the COVID-19 pandemic on cancer screenings in Portugal". Cancer Epidemiology (2024): https://doi.org/10.1016/j.canep.2023.102496.
    10.1016/j.canep.2023.102496
  3. Figueiredo, D.; Ribeiro, I.; Penedones, A.; Mendes, D.; Alves, C.; Batel-Marques, F.; da Silva, D.P.. "Correction to: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis (BMC Women's Health, (2023), 23, 1, (96), 10.1186/s12905-023-02219-0)". BMC Women's Health 24 1 (2024): http://www.scopus.com/inward/record.url?eid=2-s2.0-85184863819&partnerID=MN8TOARS.
    10.1186/s12905-024-02927-1
  4. Carlos Alves; Ana Penedones; Diogo Mendes; Francisco Batel Marques. "Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis". International Journal of Clinical Pharmacy (2023): https://doi.org/10.1007/s11096-023-01569-x.
    10.1007/s11096-023-01569-x
  5. Figueiredo D; Ribeiro I; Penedones A; Mendes D; Alves C; Batel-Marques F; da Silva DP. "Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.". BMC women's health (2023): https://europepmc.org/articles/PMC9999620.
    10.1186/s12905-023-02219-0
  6. Mendes, Diogo; Alves, Carlos; Penedones, Ana; Costa, Beatriz; Batel Marques, Francisco. "The European Health Technology Assessment Regulation and its Potential Impact on Access to the Medicines Market: What do Professionals in the Field Think?". (2023): https://doi.org/10.25756/rpf.v15i1-2.310.
    https://doi.org/10.25756/rpf.v15i1-2.310
  7. Mendes, D.; Penedones, A.; Alves, C.; Oliveira, T.; Donato, A.; Batel-Marques, F.. "Ibandronate in the Prevention of Vertebral and Nonvertebral Osteoporotic Fractures: A Systematic Review of Experimental and Observational Studies". Journal of Clinical Rheumatology 29 2 (2023): 78-83. http://www.scopus.com/inward/record.url?eid=2-s2.0-85148678538&partnerID=MN8TOARS.
    10.1097/RHU.0000000000001902
  8. Carlos Alves; Ana Penedones; Diogo Mendes; Francisco Batel Marques. "The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis". European Journal of Clinical Pharmacology (2022): https://doi.org/10.1007/s00228-022-03400-4.
    10.1007/s00228-022-03400-4
  9. Alves, C.; Penedones, A.; Mendes, D.; Marques, F.B.. "Risk of Cardiovascular and Venous Thromboembolic Events Associated with Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis". Journal of Clinical Rheumatology 28 2 (2022): 69-76. http://www.scopus.com/inward/record.url?eid=2-s2.0-85123437330&partnerID=MN8TOARS.
    10.1097/RHU.0000000000001804
  10. Alves, C.; Penedones, A.; Mendes, D.; Marques, F.B.. "The Risk of Infections Associated with JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis". Journal of Clinical Rheumatology 28 2 (2022): 407-414. http://www.scopus.com/inward/record.url?eid=2-s2.0-85111361158&partnerID=MN8TOARS.
    10.1097/RHU.0000000000001749
  11. Abrantes, J. R.; Tavares, I.; Penedones, A.; Figueiredo, D.; Mendes, D.; Alves, C.; Marques, F. B.. "The Impact of the COVID-19 Pandemic on Spontaneous Reporting of Adverse Drug Reactions in the Central Region of Portugal". Drug Safety (2022): https://publons.com/wos-op/publon/59277339/.
  12. Tavares, I.; Penedones, A.; Abrantes, J. R.; Mendes, D.; Codeco, C.; Rigueiro, G.; Alves, C.; Marques, F. B.. "Adverse Reactions Associated with Comirnaty® Among Healthcare Professionals: A Cohort Event Monitoring Study in a Portuguese Hospital". Drug Safety (2022): https://publons.com/wos-op/publon/59277342/.
  13. Mendes, Diogo. "Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses.". BMJ open (2020): https://europepmc.org/articles/PMC7780510.
    10.1136/bmjopen-2020-041420
  14. Diogo Mendes; Ana Penedones; Michele Martins; Susana Cavadas; Carlos Alves; Francisco Batel-Marques; Mendes, Diogo; et al. "Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients". Clinical Case Reports 8 12 (2020): 3432-3439. https://doi.org/10.1002/ccr3.3427.
    10.1002/ccr3.3427
  15. Diogo Mendes; Joana Abrantes; Graça Rigueiro; Ana Filipa Pais; Ana Penedones; Carlos Alves; Francisco Batel-Marques. "Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital". Journal of Oncology Pharmacy Practice (2020): https://doi.org/10.1177/1078155220957079.
    10.1177/1078155220957079
  16. Ribeiro, Inês; Batel-Marques, Francisco; Mendes, Diogo; Alves, Carlos. "A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities.". Ophthalmic epidemiology (2020): https://doi.org/10.1080/09286586.2020.1792938.
    10.1080/09286586.2020.1792938
  17. Mendes, Diogo; Oliveira, Ana Rita; Alves, Carlos; Batel-Marques, Francisco. "Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis.". Expert opinion on drug safety (2020): https://doi.org/10.1080/14740338.2020.1743262.
    10.1080/14740338.2020.1743262
  18. Diogo Mendes; Graça Rigueiro; Rui S Silva; Ana Penedones; Carlos Alves; Gabriela Sousa; Francisco Batel-Marques. "Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital". Journal of Oncology Pharmacy Practice (2020): 107815521984927-107815521984927. https://doi.org/10.1177/1078155219849277.
    10.1177/1078155219849277
  19. Batel-Marques, F.; Pereira, D.; Mendes, D.; Alves, C.; Penedones, A.. "REAL-WORLD OUTCOMES VERSUS CLINICAL TRIALS RESULTS WITH DIPEPTIDYL PEPTIDASE-4 INHIBITORS: A SYSTEMATIC REVIEW PROTOCOL". Diabetes Technology & Therapeutics (2020): https://publons.com/wos-op/publon/49303990/.
  20. Diogo Mendes; Carlos Alves; Nuno Silverio; Francisco Batel Marques. "Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis". European Thyroid Journal (2019): 1-14. https://doi.org/10.1159/000499751.
    10.1159/000499751
  21. Diogo Mendes; Carlos Alves; Márcia Loureiro; Ana Fonte; Francisco Batel-Marques. "Drug-induced hypersensitivity: A 5-year retrospective study in a hospital electronic health records database". Journal of Clinical Pharmacy and Therapeutics 44 1 (2019): 54-61. https://doi.org/10.1111/jcpt.12752.
    10.1111/jcpt.12752
  22. Batel-Marques, Francisco; Pereira, Diogo; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Mendes, Diogo. "Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review". BMJ Open (2019): http://hdl.handle.net/10316/106839.
    https://doi.org/10.1136/bmjopen-2019-032522
  23. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Segurança de Antidiabéticos Orais: Análise de Desproporcionalidade no Sistema Português de Farmacovigilância". (2019): https://doi.org/10.25756/rpf.v11i2-3.217.
    https://doi.org/10.25756/rpf.v11i2-3.217
  24. Alves, C.; Mendes, D.; Marques, F.B.. "Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis". European Journal of Clinical Pharmacology 75 10 (2019): 1431-1443. http://www.scopus.com/inward/record.url?eid=2-s2.0-85068840116&partnerID=MN8TOARS.
    10.1007/s00228-019-02713-1
  25. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "Statins and risk of cataracts: a systematic review and meta-analysis of observational studies". Cardiovascular therapeutics (2018): https://doi.org/10.1111/1755-5922.12480.
    10.1111/1755-5922.12480
  26. Alves, Carlos; Ribeiro, Inês; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "Risk of Ophthalmic Adverse Effects in Patients Treated with MEK Inhibitors: A Systematic Review and Meta-Analysis". Ophthalmic Research 57 1 (2017): 60-69.
    Published • 10.1159/000446845
  27. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Number needed to treat (NNT) in clinical literature: an appraisal". BMC Medicine 15 1 (2017): 1-13.
    Published • 10.1186/s12916-017-0875-8
  28. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Benefit–Risk of Therapies for Relapsing–Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis". CNS Drugs 30 10 (2016): 909-929.
    Published • 10.1007/s40263-016-0377-9
  29. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons". Expert Opinion on Drug Safety 15 10 (2016): 1301-1312.
    Published • 10.1080/14740338.2016.1217989
  30. Alves, Carlos; Penedones, Ana; Mendes, Diogo; Batel Marques, Francisco. "A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment". Acta Ophthalmologica 94 5 (2016): e251-e259.
    Published • 10.1111/aos.12931
  31. Batel Marques, Francisco; Penedones, Ana; Mendes, Diogo; Alves, Carlos. "Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance Unit". Journal of Patient Safety NA (2016): 1-1.
    Published • 10.1097/pts.0000000000000273
  32. Batel-Marques, Francisco; Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "A systematic review of observational studies evaluating costs of adverse drug reactions". ClinicoEconomics and Outcomes Research 8 NA (2016): 413-426. http://hdl.handle.net/10316/108522.
    Published • https://doi.org/10.2147/CEOR.S115689
  33. Mendes, Diogo; Alves, Carlos; Afonso, Noémia; Cardoso, Fátima; Passos-Coelho, José Luís; Costa, Luís; Andrade, Sofia; Batel Marques, Francisco. "The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review". Breast Cancer Research 17 1 (2015): 1-14.
    Published • 10.1186/s13058-015-0648-2
  34. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Number needed to harm in the post-marketing safety evaluation: results for rosiglitazone and pioglitazone". Pharmacoepidemiology and Drug Safety 24 12 (2015): 1259-1270.
    Published • 10.1002/pds.3874
  35. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Drug-Induced Ocular Adverse Reactions: Review of the Safety Alerts Issued During the Last Decade". Journal of Ocular Pharmacology and Therapeutics 31 5 (2015): 258-268.
    Published • 10.1089/jop.2014.0165
  36. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel-Marques, Francisco. "Segurança dos Medicamentos Biológicos Oftálmicos: Revisão Sistemática". Revista Portuguesa de Farmacoterapia 7 1 (2015): 28-44.
    Published
  37. Batel-Marques, Francisco; Mendes, Diogo; Alves, Carlos; Penedones, Ana; Dias, Patrícia; Martins, Angelina; Santiago, Luiz Miguel; et al. "Farmacovigilância em Portugal: Atividade da Unidade Regional do Centro". Acta Médica Portuguesa 28 2 (2015): 222-222. http://hdl.handle.net/10316/108936.
    Published • https://doi.org/10.20344/amp.5717
  38. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "SAFETY OF OPHTHALMIC BIOLOGICS: A SYSTEMATIC REVIEW". (2015): https://doi.org/10.25756/rpf.v7i1.16.
    https://doi.org/10.25756/rpf.v7i1.16
  39. Penedones, Ana; Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety Monitoring of Ophthalmic Biologics: A Systematic Review of Pre- and Postmarketing Safety Data". Journal of Ocular Pharmacology and Therapeutics 30 9 (2014): 729-751.
    Published • 10.1089/jop.2013.0206
  40. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events". Journal of Clinical Pharmacy and Therapeutics 39 3 (2014): 307-313.
    Published • 10.1111/jcpt.12148
  41. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports". Journal of Nursing Management 22 3 (2014): 322-330.
    Published • 10.1111/jonm.12003
  42. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events". Clinical Rheumatology 32 8 (2013): 1207-1214.
    Published • 10.1007/s10067-013-2256-9
  43. Barata, I.; Alves, C.; Mendes, D.; Fontes Ribeiro, C.; Batel Marques, F.. "The Preventability of Adverse Drug Reactions Occurring With Antineoplastic Drugs-An Evaluation of Spontaneously Reported Cases". Drug Safety (2013): https://publons.com/wos-op/publon/49304035/.
  44. Mendes, Diogo; Alves, Carlos; Batel Marques, Francisco. "Iatrogenia grave desconhecida, notificações e notificadores: resultados da actividade da Unidade de Farmacovigilância do Centro". Revista Portuguesa de Medicina Geral e Familiar 28 1 (2012): 34-40.
    Published
Newsletter article
  1. Batel-Marques, Francisco; Penedones, Ana; Alves, Carlos; Mendes, Diogo. "Métodos de Síntese de Evidência Científica", Boletim do CIM Janeiro-Março 2023, 2023, https://www.ordemfarmaceuticos.pt/fotos/publicacoes/boletim_jan_mar_2023_781047991646ce4e9eca47.pdf.
  2. Alves, Carlos; Mendes, Diogo; Batel-Marques, Francisco. "O papel da avaliação económica na seleção de medicamentos", Boletim do CIM Janeiro-Março 2019, 2019, https://www.ordemfarmaceuticos.pt/pt/publicacoes/boletim-do-cim/boletim-do-cim-jan-mar-2019/.
Thesis / Dissertation
  1. Mendes, Diogo Manuel de Jesus. "Benefit-risk assessment of medicines: a contribution for evidence-based decisions using the number needed to treat to benefit or to harm". PhD, 2017. http://hdl.handle.net/10316/41711.
  2. Mendes, Diogo Manuel de Jesus. "Iatrogenia de medicamentos biológicos indicados no tratamento da artrite reumatóide : análise de notificações espontâneas de suspeitas de reações adversas em Portugal". Master, 2012. http://hdl.handle.net/10316/22065.

Other

Other output
  1. Impact of the Covid-19 Pandemic on Cancer Screenings in Portugal. 2023. Mendes, D.; Figueiredo, D.; Alves, C.; Penedones, A.; Costa, B.; Batel-Marques, F.. http://www.scopus.com/inward/record.url?eid=2-s2.0-85171248647&partnerID=MN8TOARS.
    10.2139/ssrn.4554335
  2. The Safety of Systemic Janus Kinase Inhibitors in Atopic Dermatitis: a Systematic Review and Network Meta-analysis. 2022. Alves, C.; Penedones, A.; Mendes, D.; Marques, F.B.. http://www.scopus.com/inward/record.url?eid=2-s2.0-85167380469&partnerID=MN8TOARS.
    10.21203/rs.3.rs-1831083/v1
  3. FARMACOVIGILÂNCIA - Atualizações de segurança de medicamentos. 2014. Macedo, Tice; Penedones, Ana; Mendes, Diogo; Alves, Carlos; Fontes Ribeiro, Carlos; Batel Marques, Francisco.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2024/02 Characterization of the comparisons established among relative effectiveness assessments in health technologies assessment LIV Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2024/02 Medication wastage in residential care homes for the elderly: a pilot study in central Portugal LIV Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Lisboa, Portugal)
2023 P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses ISPOR Europe 2023
ISPOR (Copenhaga, Denmark)
2020 A comparison between the effectiveness in clinical practice versus the efficacy in clinical trials of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: protocol for systematic review L Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2019/01/25 e-Health and digital data sources for drug safety surveillance PharmV Onco Pharmacovigilance Conference
(Coimbra, Portugal)
2019 Intensive drug safety monitoring program: results of a pilot study in a portuguese oncology hospital XLIX Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2017 The use of the number needed to treat (NNT) in clinical research and practice XLVII Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Coimbra, Portugal)
2017 Statins use and development of cataract: a systematic review and cumulative meta-analysis XLVII Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Coimbra, Portugal)
2017 Systematic reviews in ophthalmology: methodological considerations XLVII Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Coimbra, Portugal)
2016 Pharmacovigilance outcomes over a six years period of time: an update XLVI Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Porto, Portugal)
2016 A systematic review and meta-analysis of the association between systemic fluoroquinolones and retinal detachment XLVI Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Porto, Portugal)
2016 Risk of ophthalmic adverse effects in cancer patients treated with MEK inhibithors: a systematic review and meta-analysis XLVI Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Porto, Portugal)
2016 Testing the use of the number needed to harm (NNH) in benefit-risk evaluations of drugs withdrawn from the European market due to safety reasons XLVI Reunião da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Porto, Portugal)
2016 Treatment with MEK Inhibitors and risk of ocular toxicity: a systematic review and meta-analysis IV Reunião Cientifica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF)
Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF) (Coimbra, Portugal)
2015 Systematic review and meta-analysis on the efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2015 Quantitative benefit-risk assessment using NNT, NNH, and LHH: a case study with rosiglitazone XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2015 Unidade de Farmacovigilância do Centro: atividades e resultados XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2015 Grading safety evidence for benefit/risk assessment: are NSAIDs na example XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2015 Ophthalmic adverse reactions induced by drugs: a review of the safety alerts issued by health regulatory authorities XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2015 Application of quantitative methodologies for benefit-risk assessment: case study with rosiglitazone and pioglitazone III Reunião Científica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF)
Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF) (Lisboa, Portugal)
2015 Grading safety evidence for benefit/risk assessment: are NSAIDs an example XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Portugal)
2015 Unidade de Farmacovigilância do Centro: atividades e resultados XLV Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (Portugal)
2014 Quantitative benefit-risk assessment of rosiglitazone: number needed to treat, number needed to harm and likelihood to be helped or harmed 14th International Society of Pharmacovigilance (ISoP) Annual Meeting
International Society of Pharmacovigilance (ISoP) (Tianjin, China)
2014 Adverse events associated with canagliflozin mechanism of action: a meta-analysis of randomized clinical trials 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting
International Society Of Pharmacovigilance (ISoP) (Tianjin, China)
2014 Drug safety signals generation using disproportionality analysis of spontaneous reporting databases – a systematic review 14th International Society Of Pharmacovigilance (ISoP) Annual Meeting
International Society Of Pharmacovigilance (ISoP) (Tianjin , China)
2013 Risk of infections and tuberculosis associated with adalimumab, etanercept and infliximab: analysis of spontaneously reported adverse drug reactions in Portugal 13th ISOP Annual Meeting
International Society of Pharmacovigilance (Pisa, Italy)
2012 Adverse drug reaction spontaneous reporting: results of ten years of activity of the regional pharmacovigilance unit of central Portugal and its contribution for drug safety knowledge XLII Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)
2012 Evaluation of the severity of adverse drug reactions reported from hospitals and ambulatory care settings: an update XLII Reunião Anual da Sociedade Portuguesa de Farmacologia (SPF)
Sociedade Portuguesa de Farmacologia (SPF) (Lisboa, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2023 - Current Razões pelas quais falha o acesso ao mercado de medicamentos em Portugal
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023 - Current Avaliação terapêutica de antineoplásicos direcionados a alterações genéticas para tomada de decisões de financiamento
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023 - Current Tratamento e acompanhamento de mulheres com endometriose e a potencial intervenção do farmacêutico
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023 - Current Avaliação do custo da perda de medicamentos essenciais por expiração de prazo de validade no centro de saúde da cidade de Lichinga
Supervisor
 Mestrado em Gestão Farmacêutica (Master)
Universidade Lúrio Faculdade de Ciências de Saúde, Mozambique
2023 - Current Caracterização e comparação de PICOs entre agências de avaliação de tecnologias de saúde e impacto na determinação de valor terapêutico acrescentado
Supervisor
 Farmacologia Aplicada (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022 - 2024 Caracterização dos processos de financiamento de medicamentos em Portugal
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022 - 2023 Análise do desperdício de medicamentos em estruturas residenciais para idosos
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022 - 2023 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento da Artrite Reumatoide
Supervisor
 Ciências Farmacêuticas (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019 - 2020 Polypharmacy as an Independent Risk Factor for Serious Adverse Drug Reactions – A Systematic Review
Supervisor
 Farmacologia Aplicada (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2019 - 2019 PharmV Onco Pharmacovigilance Conference: an event to join health professionals in order to address the safety aspects of drug treatments within healthcare process. (2019 - 2019)
Conference (Member of the Organising Committee)
 ONCONET SUDOE, France

Event participation

Activity description
Type of event 		Event name
Institution / Organization
2016 - 2016 Resultados da atividade da Unidade de Farmacovigilância do Centro
Meeting
 II Encontro Regional de Farmacovigilância
Unidade de Farmacovigilância do Centro, Portugal
2016 - 2016 A Farmacovigilância: metodologias
Conference
 Monitorização intensiva nas farmácias - novos antidiabéticos
Unidade de Farmacovigilância do Centro, Portugal
2015 - 2015 Resultados da atividade da Unidade de Farmacovigilância do Centro
Meeting
 Encontro Regional de Farmacovigilância
Unidade de Farmacovigilância do Centro, Portugal
2015 - 2015 Notificação de reações adversas
Conference
 7º Encontro Nacional das Unidades de Saúde Familiar (USF)
Associação Nacional de Unidades de Saúde Familiar (USF-AN), Portugal
2014 - 2014 Procedimentos de Notificação
Conference
 Boas Práticas na Prescrição
Agrupamentos de centros de saúde (ACeS) do Baixo Mondego, Portugal
2012 - 2012 Farmacovigilância
Conference
 XIII Jornadas de Ciências Farmacêuticas
Núcleo de Ciências Farmacêuticas da Associação de Estudantes do Instituto Superior de Ciências de Saúde do Norte (ISCS-N), Portugal
2012 - 2012 Sistema Nacional de Farmacovigilância: Noções Gerais e Procedimentos de Notificação de Suspeitas de Reações Adversas a Medicamentos
Workshop
Unidade de Farmacovigilância do Centro, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2023/10/19 Medicines Wastage in Portugal
(Thesis) Main arguer
 Neuza Alexandra Moreira Joaquim (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/16 Characterization of the Comparisons Established for Pharmacotherapeutic Evaluation in Health Technologies Assessment
(Thesis) Main arguer
 Catarina Salazar Ribeiro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/13 Impactos no custo dos medicamentos decorrentes de cenários de incerteza
(Thesis) Arguer
 Guilherme Coutinho Rato Baleiras (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/13 Characterization of the pharmacotherapeutic evaluation processes of medicines used in the treatment of Inflammatory Bowel Diseases
(Thesis) Main arguer
 Ana Isabel Noronha Sousa (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/07/25 Caracterização dos processos de avaliação terapêutica de medicamentos utilizados no tratamento de cancro do pulmão
(Thesis) Main arguer
 Catarina Garcia Abrantes (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/10/14 Vacinas contra a COVID-19: efeito secundário hipertensão arterial
(Thesis) Main arguer
 Diogo Filipe Pereira de Castro (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/09/26 A Efetividade do Alemtuzumab no Tratamento da Esclerose Múltipla
(Thesis) Main arguer
 Carolina Neiva Pereira (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2022/06 Patient Safety: Cardio and Cerebrovascular Risk of Major Adverse Events following exposure to Potentially Inappropriate Medications
Thesis Member
 João Pedro Teixeira Aguiar (PhD)
Universidade de Lisboa, Portugal
2022 Dispositivos de Auxílio à Administração de Medicamentos
(Thesis) Main arguer
 Catarina da Silva Almeida (Master)
2020 Efetividade na prática clínica vs eficácia em ensaios clínicos dos inibidores da dipeptidil peptidase-4 no tratamento da diabetes tipo 2 – revisão sistemática
(Thesis) Main arguer
 Diogo Emanuel de Pina e Pereira (Master)
Universidade de Coimbra Faculdade de Farmácia, Portugal

Association member

Society Organization name Role
2023 - Current ISPOR - The Professional Society for Health Economics and Outcomes Research
2023 - Current DIA - Drug Information Association
2016 - Current Sociedade Portuguesa de Farmacologia
2012 - Current Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia
2009 - Current Ordem dos Farmacêuticos

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022/05 - Current Acesso ao Mercado Curso de Especialização em Gestão e Direção em Saúde (Postgraduate Certificate) Universidade de Coimbra, Portugal
2023 - 2023 Economia da Saúde Mestrado em Gestão Farmacêutica (Master) Universidade Lúrio Faculdade de Ciências de Saúde, Mozambique
2022/07 - 2022/07 Segurança de medicamentos, Farmacovigilância e Farmacoepidemiologia Pós-graduação em medicina farmacêutica Universidade Nova de Lisboa Medical School, Portugal
2020/11 - 2021 Medicines under additional surveillance (Safety and risk management in the real-world clinical practice) Medicines and Medical Devices (Pós-Graduação) AHED - Advanced Health Education, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia: Organização da informação de suporte à tomada de decisão terapêutica Aperfeiçoamento (Curso médio) Escola de Pós-graduação em Saúde e Gestão, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia: Princípios gerais da avaliação económica de medicamentos Aperfeiçoamento (Curso médio) Escola de Pós-graduação em Saúde e Gestão, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia: Workshop I, II e III Aperfeiçoamento (Curso médio) Escola de Pós-graduação em Saúde e Gestão, Portugal
2013 - 2013 Curso de Pós-Graduação em Farmacoterapia: Módulo VI - Farmacoterapia Avançada Aperfeiçoamento (Curso médio) Escola de Pós-graduação em Saúde e Gestão, Portugal

Interview (tv / radio show)

Program Topic
2024/02/23 - 2024/02/23 Podcast - Sob a Lupa da Investigação Clínica Adequação do desenho de ensaios clínicos às exigências para obtenção de uma AIM e um parecer favorável de financiamento público pelas agências de ATS

Journal scientific committee

Journal title (ISSN) Publisher
2023 - Current Frontiers in Drug Safety and Regulation (2674-0869) Frontiers
2021 - Current Frontiers in Pharmacology (1663-9812) Frontiers
2020 - Current Healthcare (2227-9032) MDPI
Distinctions

Other distinction

2017 Prémio de Investigação Científica Professora Doutora Maria Odette Santos-Ferreira
Ordem dos Farmaceuticos, Portugal
2015 Primeiro Prémio (melhor comunicação científica) - III Reunião Científica Anual da Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF)
Sociedade Portuguesa de Farmácia Clínica e Farmacoterapia (SPFCF), Portugal